Task: Answer Verification
Input (English): Question: Does early remission status predict long-term outcomes in patients with Crohn 's disease treated with certolizumab pegol?
Answer: In certolizumab pegol-treated patients with CD, ER appears to be an important predictor of long-term clinical remission. Prospective trials are needed to determine whether ER improves other long-term outcomes.
Output (English): yes